One of the molecular markers with the highest prognostic/predictive impact in glioblastoma is the methylation status of the promoter of the O6-methylguanine DNA methyltransferase (MGMT) gene, which encodes for an enzyme involved in the DNA repair system. This evidence concerns the gene MGMT and glioblastoma.